Want to see IN:CHEMFAB full AI Analyst Report?
Top Page
Chemfab Alkalis Ltd.
(CHEMFAB)
Select Model
Select Model
Rating:47Neutral
Price Target:
₹365.00
▼(-14.31% Downside)
Action:Reiterated
Date:08/18/26
Overall score is driven primarily by weakened financial performance: the return to losses, negative operating profit in FY2026, and volatile/free-cash-flow pressure (including deeply negative FY2026 FCF) outweigh the still relatively supportive balance sheet. Technicals add downside bias as the price trades below key moving averages, while valuation provides little offset given a negative P/E and low dividend yield.
Positive Factors
Equity-supported balance sheet
Substantial equity support and a historically low-leverage profile provide resilience during weaker earnings periods. Although debt has risen recently, the existing capital base may help the company fund operations and manage cyclical pressure.
Negative Factors
Revenue contraction
Recent revenue contraction signals weaker demand, pricing, or product mix and reduces operating leverage. If the decline persists, lower scale could make it harder to absorb fixed costs and restore sustainable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Equity-supported balance sheet
Substantial equity support and a historically low-leverage profile provide resilience during weaker earnings periods. Although debt has risen recently, the existing capital base may help the company fund operations and manage cyclical pressure.
Read all positive factors
Chemfab Alkalis Ltd. (CHEMFAB) vs. iShares MSCI India ETF (INDA)
Market Cap
₹5.53B
Dividend Yield0.33%
Average Volume (3M)293.00
Price to Earnings (P/E)―
Beta (1Y)1.06
Revenue Growth-16.24%
EPS Growth95.39%
CountryIN
Employees219
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-0.16
Shares Outstanding14,373,702
10 Day Avg. Volume441
30 Day Avg. Volume293
Financial Highlights & Ratios
PEG Ratio2.41
Price to Book (P/B)1.12
Price to Sales (P/S)1.36
P/FCF Ratio-6.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Chemfab Alkalis Ltd. Business Overview & Revenue Model
Company Description
Established in 1985 and headquartered in Chennai, India, Chemfab Alkalis Limited is an international manufacturer and vendor of inorganic chemical products. The company's business activities are structured around two main segments: Chemicals and R...
How the Company Makes Money
null...
Chemfab Alkalis Ltd. Financial Statement Overview
Summary
Income Statement
41
Neutral
Balance Sheet
68
Positive
Cash Flow
46
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.93B | 3.11B | 3.34B | 3.27B | 3.31B | 2.71B |
| Gross Profit | 457.23M | 410.05M | 1.16B | 573.09M | 1.57B | 972.61M |
| EBITDA | 333.75M | 359.06M | 444.34M | 632.53M | 1.13B | 624.45M |
| Net Income | -2.44M | -34.27M | -69.40M | 263.23M | 645.83M | 287.47M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 5.77B | 5.22B | 5.00B | 4.12B | 3.52B |
| Cash, Cash Equivalents and Short-Term Investments | 143.98M | 143.98M | 211.84M | 76.98M | 692.16M | 328.37M |
| Total Debt | 0.00 | 1.26B | 843.41M | 201.11M | 23.57M | 86.47M |
| Total Liabilities | -3.75B | 2.01B | 1.42B | 1.13B | 507.42M | 541.82M |
| Stockholders Equity | 3.75B | 3.75B | 3.80B | 3.87B | 3.61B | 2.98B |
Cash Flow | ||||||
| Free Cash Flow | -652.58M | -603.87M | 399.09M | -605.69M | 349.82M | 347.13M |
| Operating Cash Flow | 112.34M | 308.32M | 399.09M | 313.54M | 925.95M | 549.10M |
| Investing Cash Flow | -511.78M | -808.36M | -859.86M | -1.10B | -475.12M | -210.25M |
| Financing Cash Flow | 204.85M | 380.62M | 587.23M | 160.65M | -88.92M | -245.73M |
Chemfab Alkalis Ltd. Technical Analysis
Positive
425.95
Price Trends
368.35
Positive
382.95
Positive
395.62
Negative
Market Momentum
0.60
Negative
60.40
Neutral
53.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CHEMFAB, the sentiment is Positive. The current price of 425.95 is above the 20-day moving average (MA) of 363.76, above the 50-day MA of 368.35, and above the 200-day MA of 395.62, indicating a neutral trend. The MACD of 0.60 indicates Negative momentum. The RSI at 60.40 is Neutral, neither overbought nor oversold. The STOCH value of 53.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:CHEMFAB.
Chemfab Alkalis Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | ₹48.22B | 32.03 | ― | 0.04% | 16.61% | 15.18% | |
60 Neutral | ₹2.92B | 19.96 | ― | 0.91% | -26.36% | -55.59% | |
58 Neutral | ₹775.60M | 73.58 | ― | 1.34% | 1.94% | ― | |
56 Neutral | ₹4.33B | 23.33 | ― | 0.19% | 25.22% | 20.38% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
49 Neutral | ₹5.03B | 14.61 | ― | 0.62% | -0.88% | 9.72% | |
47 Neutral | ₹5.53B | -2,370.94 | ― | 0.33% | -16.24% | 95.39% |
* General Sector Average
IN:CHEMFAB
Chemfab Alkalis Ltd.
384.40
-255.05
-39.89%
IN:AARTISURF
Aarti Surfactants Ltd.
511.40
21.75
4.44%
IN:ALKALI
Alkali Metals Ltd.
76.17
-15.50
-16.91%
IN:CHEMBOND
Chembond Chemicals Limited
217.45
38.30
21.38%
IN:SUKHJITS
Sukhjit Starch & Chemicals Ltd.
160.85
-10.10
-5.91%
IN:VISHNU
Vishnu Chemicals Limited
716.35
213.69
42.51%
Chemfab Alkalis Ltd. Corporate Events
Chemfab Alkalis Corrects AGM Notice, Confirms Dividend and Governance Items
Aug 18, 2026
Chemfab Alkalis Limited has issued a corrigendum to its previously circulated notice for the 17th Annual General Meeting, correcting typographical errors in the serial numbering of special business agenda items. The revised numbering clarifies tha...
Chemfab Alkalis Schedules Virtual 17th AGM for September 2026
Aug 18, 2026
Chemfab Alkalis Ltd. has announced that its 17th Annual General Meeting will be held on 9 September 2026 via video conferencing and other audio-visual means, enabling shareholders to participate remotely. This format aligns with evolving corporate...
Chemfab Alkalis moves AGM online and urges investors to update KYC, access FY26 report via web link
Aug 18, 2026
Chemfab Alkalis Ltd. has notified the stock exchanges that it has sent letters to shareholders whose email addresses are not registered, providing a web link to access the company’s Annual Report for FY 2025-26. This move ensures regulatory ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.